Encompass Health Corp Stockholders Equity

• Encompass Health Corp showed an increase of +18.0% in Stockholders Equity from 2024 to 2025.
• This data is from Encompass Health Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2009: -$1.05 billion | Q3 2009: -$921.90 million | Q4 2009: -$897.60 million | Q1 2010: -$861.90 million | Q2 2010: -$817.30 million | Q3 2010: -$782.30 million | Q1 2011: $72.30 million | Q2 2011: $96.60 million | Q3 2011: $151.80 million | Q1 2012: $149.40 million | Q2 2012: $195.80 million | Q3 2012: $244.70 million | Q1 2013: $108.30 million | Q2 2013: $274.80 million | Q3 2013: $321.10 million | Q1 2014: $355.60 million | Q2 2014: $413.70 million | Q3 2014: $449.60 million | Q1 2015: $492.30 million | Q2 2015: $605.90 million | Q3 2015: $630.40 million | Q1 2016: $649.50 million | Q2 2016: $672.70 million | Q3 2016: $726.30 million | Q1 2017: $779.70 million | Q2 2017: $1.10 billion | Q3 2017: $1.14 billion | Q1 2018: $1.20 billion | Q2 2018: $1.25 billion | Q3 2018: $1.32 billion | Q1 2019: $1.31 billion | Q2 2019: $1.28 billion | Q3 2019: $1.33 billion | Q1 2020: $1.44 billion | Q2 2020: $1.46 billion | Q3 2020: $1.52 billion | Q1 2021: $1.66 billion | Q2 2021: $1.76 billion | Q3 2021: $1.84 billion | Q1 2022: $1.97 billion | Q2 2022: $2.00 billion | Q3 2022: $1.22 billion | Q1 2023: $1.38 billion | Q2 2023: $1.48 billion | Q3 2023: $1.56 billion | Q1 2024: $1.74 billion | Q2 2024: $1.84 billion | Q3 2024: $1.96 billion | Q1 2025: $2.16 billion | Q2 2025: $2.28 billion | Q3 2025: $2.37 billion.
• Over the full 19 years of available data (2007 to 2025), Encompass Health Corp's Stockholders Equity has grown by 267.3%.
• Historical annual values: Fiscal year 2025: $2.44 billion | Fiscal year 2024: $2.07 billion | Fiscal year 2023: $1.65 billion | Fiscal year 2022: $1.31 billion | Fiscal year 2021: $1.91 billion | Fiscal year 2020: $1.59 billion | Fiscal year 2019: $1.35 billion | Fiscal year 2018: $1.28 billion | Fiscal year 2017: $1.15 billion | Fiscal year 2016: $735.90 million | Fiscal year 2015: $611.40 million | Fiscal year 2014: $473.20 million | Fiscal year 2013: $344.60 million | Fiscal year 2012: $291.00 million | Fiscal year 2011: $117.00 million | Fiscal year 2010: -$85.20 million | Fiscal year 2009: -$897.60 million | Fiscal year 2008: -$1.09 billion | Fiscal year 2007: -$1.46 billion.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026